https://mt.prisysbiotech.com/ Mhux - Bniedem Primati Riċerka Pjattaforma & CRO | PRISYS Bijoteknoloġija https://mt.prisysbiotech.com/uploads/39406/logo.png https://mt.prisysbiotech.com/safety-evaluation/ Evalwazzjoni tas-Sigurtà https://mt.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://mt.prisysbiotech.com/translation-research/ Riċerka dwar it-Traduzzjoni https://mt.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://mt.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://mt.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://mt.prisysbiotech.com/nhp-pharmacology/ Farmakoloġija NHP https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/biosafety-research/ Riċerka dwar il-Bijosigurtà https://mt.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://mt.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://mt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://mt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://mt.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://mt.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://mt.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://mt.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://mt.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://mt.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://mt.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://mt.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://mt.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://mt.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://mt.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://mt.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://mt.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://mt.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://mt.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://mt.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://mt.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://mt.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://mt.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://mt.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://mt.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://mt.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://mt.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://mt.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://mt.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://mt.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://mt.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://mt.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://mt.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://mt.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://mt.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://mt.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://mt.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://mt.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://mt.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://mt.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://mt.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://mt.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://mt.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://mt.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://mt.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://mt.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://mt.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://mt.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://mt.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://mt.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://mt.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://mt.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://mt.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://mt.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://mt.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://mt.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://mt.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://mt.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://mt.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://mt.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://mt.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://mt.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://mt.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://mt.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://mt.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://mt.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://mt.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://mt.prisysbiotech.com/pk-pd-adme/adme.html ADME https://mt.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://mt.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://mt.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://mt.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://mt.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://mt.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://mt.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://mt.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://mt.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://mt.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://mt.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://mt.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://mt.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://mt.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://mt.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://mt.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://mt.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://mt.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://mt.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://mt.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://mt.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://mt.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://mt.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://mt.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://mt.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://mt.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://mt.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://mt.prisysbiotech.com/translation-research/clinical-imaging.html Immaġini Kliniċi https://mt.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Immaġini Kliniċi https://mt.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://mt.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://mt.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://mt.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://mt.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://mt.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://mt.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://mt.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://mt.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://mt.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://mt.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://mt.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://mt.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://mt.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://mt.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://mt.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://mt.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://mt.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://mt.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Mudell tad-Dijabete Mellitus tat-Tip 2 https://mt.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Mudell tad-Dijabete Mellitus tat-Tip 2 https://mt.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://mt.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://mt.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://mt.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://mt.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://mt.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://mt.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://mt.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://mt.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://mt.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://mt.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://mt.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://mt.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://mt.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://mt.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://mt.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://mt.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://mt.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://mt.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://mt.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://mt.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://mt.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://mt.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://mt.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://mt.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://mt.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://mt.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://mt.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://mt.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://mt.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://mt.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://mt.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://mt.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://mt.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://mt.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://mt.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://mt.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://mt.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://mt.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://mt.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://mt.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://mt.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://mt.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://mt.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://mt.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://mt.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://mt.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://mt.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://mt.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://mt.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://mt.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://mt.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://mt.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://mt.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://mt.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://mt.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://mt.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://mt.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://mt.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://mt.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003095074071552.html Immaġini Molekulari f'Mudelli NHP Għall-Iżvilupp ta 'Droga Translazzjonali https://mt.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://mt.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17968190057292800.html Webinar ta' l-NHP BehaviorAtlas|3D NHP Behavioral Tracking Għall-Iżvilupp tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://mt.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724393223676928.html Recap 2025: Kif Prisys Qed tiddefinixxi mill-ġdid l-Affidabbiltà Translazzjonali fir-Riċerka NHP https://mt.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://mt.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17562072657486848.html NHP - Farmakoloġija bbażata u servizzi farmakodinamiċi|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://mt.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17532230970778624.html Iltaqa 'ma' Prisys Biotech fi Roadshow li jmiss ta 'l-UE: Settembru 2025 https://mt.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://mt.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17457281938695168.html Prisys Biotech - 2025 Reviżjoni ta 'Nofs is-Sena https://mt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://mt.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243517355140096.html Iltaqa 'ma' Prisys fil-US-Roadshow li jmiss f'Marzu 2025 https://mt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://mt.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83992149.html Rapport Annwali PRISYS 2024: Mudelli NHP Avvanzati U Riċerka Preklinika https://mt.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://mt.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77818722.html Prisys Biotech 2024 Q2 Newsletter - R&D Prekliniċi Mtejba Għat-Terapewtika CNS B'Mudelli Cross-reactive PRISYS https://mt.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://mt.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028059374969856.html Għaliex Mudelli tal-Annimali Jirnexxu jew Fallu fl-Iżvilupp tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021130159629312.html Ingaġġ Kwantitattiv fil-Mira tal-PET f'NHPs Għal Drogi CNS https://mt.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://mt.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18014898944320512.html Mill-Vidjo Sad-Dejta: Traċċar 3D AI Għall-Imġieba NHP https://mt.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://mt.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18014970361308160.html Immaġini tal-Bijodistribuzzjoni tal-PET fi Primati Mhux-Bniedem https://mt.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://mt.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003096099480576.html PBPK vs. Mudelli Kompartimentali: Għaliex Jgħodd il-PBPK https://mt.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://mt.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993010294236160.html Recap tal-Webinar: Avvanz tar-Riċerka Translazzjonali tal-NHP Permezz tal-Fenotipi Diġitali tal-Imġieba https://mt.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://mt.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990296716403712.html Bijomarkaturi PK fl-Iżvilupp Prekliniku tad-Droga|Espożizzjoni–Rispons & PK/PD https://mt.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://mt.prisysbiotech.com/news/behavior-in-rhesus-17983440927990784.html Awto-Spontanju-Imġieba Dannuża f'Rhesus Macaques: Mudell Translazzjonali ta' NHP Għall-Iżvilupp ta' Drogi Newropsikjatriċi https://mt.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://mt.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17983441040008192.html Mudelli ta 'Effikaċja MIDD U NHP fl-Iżvilupp ta' Droga Translazzjonali https://mt.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://mt.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17973616978715648.html AI-Analiżi tal-Imġieba tal-NHP 3D imħaddma|Fenotipar tal-Imġieba mingħajr Marker https://mt.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://mt.prisysbiotech.com/news/webinar-nhp-behavioratlas-17973617172358144.html Webinar Globali|Kwantifikazzjoni tal-Imġieba Kumpless tal-NHP: L-introduzzjoni tal-NHP BehaviorAtlas Għal-Fenotipi tal-Imġieba 3D ta' Fedeltà Għolja https://mt.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://mt.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17968190422541312.html AI-Analiżi tal-Imġieba tal-NHP Powered Għall-Iżvilupp Prekliniku tad-Droga|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://mt.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17973617491534848.html Meta Tintroduċi Studji NHP fl-Iżvilupp Awtoimmuni tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://mt.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17973617641186304.html Mudelli NHP IBD: X'Tgħallimna Enterokolite Kronika F'Rhesus Macaques Dwar Infjammazzjoni Translazzjonali tal-Imsaren https://mt.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://mt.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17973617204470784.html MRI-Twassil Iggwidat tal-AAV f'Mudelli tal-Moħħ NHP għat-terapija tal-ġeni tas-CNS https://mt.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://mt.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17973617211106304.html Għaliex id-Drogi ta 'Kontroll Pożittiv Jgħoddu f'Mudelli ta' Mard Awtoimmuni|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://mt.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17973616911459328.html Skrinjar tal-ADA tal-linja bażi f'xadini maħsul-Out għal Studji Bijoloġiċi Prekliniċi https://mt.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://mt.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17968190188692480.html Mekkaniżmi ta 'Uġigħ: Il-Mudell ta' Ħruq mix-Xemx UVB Huwa Għodda Vitali ta 'Traduzzjoni https://mt.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://mt.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17968189947634688.html Mudelli ta' NHP Ta' Dieta Għolja-Omm ta' Xaħam U Programmazzjoni ta' Obeżità fit-Tfulija https://mt.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://mt.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17940778960167936.html Interpretazzjoni tal-Patoloġija Klinika fi Klieb U Primati Mhux Umani fi Studji Prekliniċi https://mt.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://mt.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17940779959952384.html Bijomarkaturi ta 'Immaġini Molekulari: Avvanz tar-Riċerka Translazzjonali U Żvilupp tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://mt.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17940779982709760.html X'inhi Farmakokinetiċi Mhux Lineari? Mekkaniżmi, Karatteristiċi, U Implikazzjonijiet Għall-Iżvilupp tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://mt.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17940778914489344.html Għaliex l-Immaġini Molekulari NHP Huwa Kritiku Għal Studji Translazzjonali tal-PET https://mt.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://mt.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17940779144291328.html X'inhu l-Immaġini Molekulari U Għaliex Huwa Importanti fl-Iżvilupp tad-Droga? https://mt.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://mt.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17940778479657984.html Studji dwar il-Bijodistribuzzjoni tar-Rajonuklidi NHP: Immaġini Molekulari Għall-Iżvilupp ta 'Droga Translazzjonali https://mt.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://mt.prisysbiotech.com/news/nhp-heart-failure-model-17940778293289984.html Mudell ta 'Insuffiċjenza tal-Qalb NHP Jappoġġja Riċerka Translazzjonali Fuq Terapija tal-Ġene tar-Restawr tat-Telomeri https://mt.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://mt.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17940778761741312.html Kif DSA u CTA Imaging Itejbu l-Evalwazzjoni tas-Sigurtà tad-Droga Kardjovaskulari https://mt.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://mt.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17940778655228928.html Mudell ta' Trombożi ta' Shunt Arteriovenuża NHP fix-xadini Cynomolgus għal Evalwazzjoni ta' Droga Antitrombotika Translazzjonali https://mt.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://mt.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888303702713344.html Dejta Farmakokinetika Bħala Bijomarkatur Translazzjonali https://mt.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://mt.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888303547442176.html Mudelli ta' Fibrożi Pulmonari mhux-Primati Umani: Avvanzament tal-Eżattezza Translazzjonali fl-Iżvilupp Respiratorju tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://mt.prisysbiotech.com/news/nhp-models-translational-drug-development-17888303741314048.html Għaliex l-Iżvilupp tad-Droga Jiddependi dejjem aktar fuq Mudelli NHP|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://mt.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888304125912064.html Dejta PK Bħala Biomarkatur Farmakodinamiku: Avvanz fl-Iżvilupp Translazzjonali tad-Droga permezz tal-Farmakoloġija Kwantitattiva https://mt.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://mt.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17851041799775232.html Studji Farmakoloġija mhux-GLP Għal Sottomissjoni Regolatorja: Integrità tad-Data u Rekwiżiti tal-Laboratorju https://mt.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://mt.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17851041505420288.html Disinn Strateġiku ta' Studji Farmakokinetiċi Mhux Kliniċi: Mill-Profili ADME Sat-Teħid ta' Deċiżjoni Translazzjonali- https://mt.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://mt.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17851041680073728.html NHP AV-Shunt Thrombosis Mudell Għall-Evalwazzjoni tas-Sigurtà tad-Droga|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://mt.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17851041803396096.html X'inhi Farmakokinetiċi Mhux Lineari? Mekkaniżmi U Evalwazzjoni PK Translazzjonali|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://mt.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17851042001740800.html Prisys Biotech Jappoġġja l-Approvazzjoni IND Ta' UX-GIP001 Mill-FDA U CDE|Pjattaforma ta' Kunsinna NHP CNS https://img01.v15cdn.com/gallery/4x3/157.webp https://mt.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17851041787864064.html In Vivo Immune Cell Tracking & PET Tracer Żvilupp f'Mudelli NHP|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://mt.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17851041557013504.html Dopamine Transporter PET Imaging f'Mudelli NHP|Immaġini tas-CNS|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://mt.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17851041556505600.html Bijodistribuzzjoni PET/CT f'Mudelli NHP Għall-Kunsinna tad-Droga CNS|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://mt.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17851041387570176.html Kbar-Radjutikkettjar ta' Annimali U Pjattaforma ta' Immaġini In Vivo Għall-Iżvilupp ta' Drogi Translazzjonali https://mt.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://mt.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17851041338319872.html Għaliex l-Iżvilupp tad-Droga Jiddependi Dejjem fuq Mudelli NHP: Ir-Rwol Essenzjali Tal-Primati fil-Mediċina Translazzjonali|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://mt.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17851041616913408.html Sfidi U Soluzzjonijiet għall-Iżvilupp tad-Droga tal-IPF|Mudelli NHP Bil CT Imaging & PFT https://mt.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://mt.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17851041316316160.html AI Markerless NHP 3D Sistema ta 'Analiżi tal-Imġieba għar-Riċerka Preklinika https://mt.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://mt.prisysbiotech.com/news/evaluating-dmpk-properties-17851041350624256.html Evalwazzjoni tal-Proprjetajiet tad-DMPK Ta' Komposti Kandidati f'Sejbien Bikri tad-Droga|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://mt.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17851041450533888.html MRI-Konsenja Ggwidata tas-CNS f'Mudelli NHP|Pjattaforma tat-Traduzzjoni IMRI & CED https://mt.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://mt.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17851041400808448.html Studji dwar il-Bijodistribuzzjoni tal-NHP CNS|Kunsinna Intrathecal RNA|PRISYS Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://mt.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17851041416930304.html Qafas Translazzjonali PK/PD: Cynomolgus Monkey To Human Dose Tbassir|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://mt.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724393290703872.html Meta Uġigħ Issir Memorja: Sewwieqa Emozzjonali Ta 'Uġigħ Kroniku & Il-Vantaġġ tal-Mudell NHP|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://mt.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724393188107264.html Multi-Valutazzjoni tal-Uġigħ Endpoint: Il-Futur tal-Iżvilupp ta' Drogi Analġeżiċi https://mt.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://mt.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724393276515328.html Għaliex Ħafna Analġeżiċi Jfallu fi Provi Prekliniċi? It-Tweġiba tinsab f'Kif Aħna Nkejlu l-Uġigħ https://mt.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://mt.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724393579586560.html Disinn ta' Punt ta' Ħin ta' Teħid ta' Kampjuni tad-Demm fi Studji Farmakokinetiċi (PK)|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://mt.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724393693668352.html Statistika PK: Parametri ta' Analiżi mhux-kompartimentali (NCA) U Applikazzjonijiet Prekliniċi https://mt.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://mt.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724393206817792.html Għaliex Mudelli Mhux-Primati Umani Huma Kritiċi Għat-Terapewtika Oligonukleotide tas-CNS https://mt.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://mt.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724393225888768.html Metaboliżmu ta 'l-Aċidu Uriku fil-Bnedmin Vs Xadini: Implikazzjonijiet Translazzjonali Għall-Iżvilupp tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://mt.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724393177326592.html Mudell tal-Fibrożi tal-Fwied mhux-Human Primate MASH-Assoċjat|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://mt.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724393269519360.html Għaliex IMRI-Twassil Iggwidat tad-Droga tal-Moħħ Huwa Essenzjali għal Immirar Preċiż fi Studji NHP https://mt.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://mt.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674691468108800.html AI-Sistema ta' Analiżi tal-Imġieba NHP 3D Mmexxija minn Markerless|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://mt.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674691483427840.html Mudell NHP LPS-Infjammazzjoni Akuta tal-Pulmun Indotta (ALI)|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://mt.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674691405931520.html Mudell HDM+SEB-Dermatite Atopika Indotta (AtD) fix-xadini Cynomolgus https://mt.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://mt.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674687074919424.html Wieħed- Għal Multi-Mudelli PK ta' Kompartiment Spjegati|Farmakokinetika NHP|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://mt.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674687049294848.html Kif Agħżel CRO Prekliniku Affidabbli|Kriterji Ewlenin Għall-Kumpaniji tal-Bijoteknoloġija|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://mt.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674686724940800.html Evalwazzjoni CAR-T Translazzjonali: Kompetenza In Vitro & Appoġġ għall-Istudju NHP — Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://mt.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674686801978368.html Għaliex Aktar Minn 90% Tal-Kandidati tad-Droga tas-CNS Fallu fil-Provi Kliniċi? https://mt.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://mt.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674698387907584.html Mudelli Prekliniċi tal-Marda ta' Parkinson: Gwida Għat-Għażla ta' Mudelli ta' Neurotossini, Ġenetiċi, U NHP|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://mt.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674686794015744.html -Kunsinna ta' Drogi ta' Preċiżjoni Għolja U Pjattaformi ta' Traduzzjoni NHP Mmexxija mill-AI- https://mt.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://mt.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17649090944017408.html Mudelli ta' Immunoloġija NHP Mmexxija minn Th17|Riċerka Awtoimmuni Translazzjonali Fuq Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://mt.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17649096905663488.html AI-Sistema BehaviorAtlas® tal-NHP|Pjattaforma tal-Analiżi tal-Imġieba 3D|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://mt.prisysbiotech.com/news/rfp-template-for-nhp-studies-17649004753462272.html Mudell RFP Għal Studji NHP|Aċċellera l-Effiċjenza tar-Riċerka Preklinika https://mt.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://mt.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17649060736558080.html Cold Allodynia Pain Mudell fix-xadini Cynomolgus|Bijoteknoloġiji Prisys https://mt.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://mt.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17649004932719616.html MRI-Pjattaforma ta' Kunsinna ta' Drogi Intraċerebrali Iggwidata|Prisys Biotech CNS Riċerka https://mt.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://mt.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17649013229937664.html Mudelli ta' Mard Respiratorju NHP U Pjattaforma ta' Kunsinna tad-Droga fil-passaġġi tal-arja|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://mt.prisysbiotech.com/news/nhp-renal-biopsy-17649023423325184.html Pjattaforma tal-Bijopsija Renali NHP U Mudelli tal-Mard tal-Kliewi|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://mt.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17648997470266368.html Studji PK & Kunsinna Immirata tad-Droga|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://mt.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17649022270055424.html Pjattaforma ta' Analiżi tal-Imġieba Bbażata fuq l-NHP ta' Prisys Biotechnologies u Riċerka u AI{0}} https://mt.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://mt.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17648997073921024.html Teknoloġija ta' Kunsinna mill-imnieħer-sal-Brain (N2B) Għar-Riċerka tas-CNS|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://mt.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17648996983415808.html SHR-2004: A Breakthrough fil-Prevenzjoni tal-VTE Għall-Pazjenti tal-Kanċer tal-Ovarji - Storja ta' Suċċess Minn Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://mt.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17542767922242560.html Mudelli ta' Xadini Cynomolgus & Rhesus|Prisys Biotech CRO Prekliniku https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17532230476964864.html Fibrożi pulmonari idjopatika (IPF) Mudell NHP|Prisys Biotech Preclinical CRO https://mt.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://mt.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17532190354367488.html Studji dwar il-Bijodistribuzzjoni tax-xadini Cynomolgus|Prisys Biotech CRO Prekliniku https://mt.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://mt.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17532190585545728.html Mudelli Prisys Biotech NHP għall-ematoloġija u r-riċerka tal-puplesija https://mt.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://mt.prisysbiotech.com/news/the-importance-of-administration-volume-17532190360249344.html L-importanza tal-volum tal-amministrazzjoni fi studji prekliniċi|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://mt.prisysbiotech.com/news/brain-targeted-drug-delivery-17532190352253952.html Moħħ - Twassil immirat ta 'mediċina|Riċerka prekliniċi tal-bijoteknoloġija tal-bijoteknoloġija https://mt.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://mt.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17532190531167232.html Żvilupp tad-Droga ADC|Qafas Translazzjonali PK/PD fi Studji Prekliniċi NHP https://mt.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://mt.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17502493727024128.html Mudelli ta 'uġigħ NHP għall-iskoperta ta' mediċina traslazzjonali|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://mt.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17502471694754816.html Serum vs. Plażma: L-Għażla tal-Matriċi Ottimal Għall-Bijoanaliżi Preklinika https://mt.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://mt.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17502471932077056.html Linji Gwida ta' Dożaġġ Prekliniku: Volum IV & PO, PH, U Osmolarità Għal PK Preċiża f'NHPs U Speċi Oħra https://mt.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://mt.prisysbiotech.com/news/nhp-copd-model-17502471807951872.html Top Mudelli ta 'Riċerka COPD & Eċċellenza tal-Pjattaforma Respiratorja minn Prisys https://mt.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://mt.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17502471646209024.html Mudell ta 'emorraġija akuta NHP: għodda kruċjali għall-aċċellerazzjoni tal-iżvilupp tal-mediċina ġdida https://mt.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://mt.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17502471667196928.html Riċerka Pruritus: Mudell NHP indott mill-IL-31 ta 'Prisys Biotech għall-Evalwazzjoni ta' Terapiji Kontra t-Tach https://mt.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://mt.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17457281944577024.html Gwida Għall-Valutazzjoni ta' Anti-Droga Antibody (ADA). https://img01.v15cdn.com/gallery/4x3/148.webp https://mt.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17457282069832704.html Terapiji Respiratorji: Pjattaforma NHP Integrata ta 'Prisys Biotech għar-Riċerka Preklinika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17457282089837568.html Mudelli ta 'Uġigħ NHP: Tħaffef l-Iżvilupp ta' Droga Analġesika fi Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://mt.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17457281809163264.html Pjattaformi tal-mudell NHP biex jappoġġjaw l-iżvilupp tad-droga f'mard kumpless https://mt.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://mt.prisysbiotech.com/news/key-considerations-for-dosing-volume-17457281991484416.html Konsiderazzjonijiet Ewlenin Għall-Volum tad-Dożar, PH, U Formulazzjoni f'Mudelli ta 'Annimali https://mt.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://mt.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17457281962353664.html Exosomes Inġinerija: Revolutionizing Kunsinna tad-Droga għal Disturbi CNS - Intuwizzjonijiet Prekliniċi Minn Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://mt.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17457281860936704.html Prinċipji ta' Gwida Għall-Għażla ta' Speċi ta' Annimali fi Studji ta' Tossikoloġija tad-Droga ta' Aċidu Nuklejku https://img01.v15cdn.com/gallery/4x3/148.webp https://mt.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17457282064180224.html DSA U IMRI ta' Prisys Biotech għal Studji Ematoloġiċi, Vaskulari, U tal-Mard Renali https://mt.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://mt.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17457281900143616.html Mudelli ta’ Uġigħ ta’ Xadina Cynomolgus: Li Jħeġġu r-Riċerka Translazzjonali Għal Terapewtika tal-Kanal tal-Ion Breakthrough https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17457282085479424.html Avvanz ta 'Riċerka dwar id-Dermatite Atopika: Mudell ta' Prisys Biotech Non-Human Primat (NHP) https://mt.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://mt.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17457281840030720.html Mudell ta 'dermatite atopika ta' Prisys Biotech NHP għall-Iżvilupp ta 'Droga Kontra l-Pruritika https://mt.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://mt.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374216603657216.html Iddisinjar ta 'Studji fuq l-Annimali: Konsiderazzjonijiet Ewlenin għas-Suċċess tar-Riċerka Preklinika https://img01.v15cdn.com/gallery/4x3/300.webp https://mt.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374216499848192.html Dermatite atopika: Kif il-mudelli ta 'Cynomolgus Monkey javvanzaw terapewtiċi ta' preċiżjoni https://mt.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://mt.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374216591451136.html Riċerka dwar l-Ażma: Għaliex Mudelli ta' Primati Mhux-Human Pivotali Għall-Iżvilupp ta' Drogi Ġdid https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374216528749568.html Nifhmu l-Farmakokinetika tal-Oligonucleotide Antisens (ASO): Fatturi Ewlenin fl-Assorbiment U d-Distribuzzjoni https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374216766743552.html Studji ta' Inalazzjoni NHP Għall-Bijoloġiċi: Servizzi Speċjalizzati CRO Prekliniċi ta' PRISYS https://img01.v15cdn.com/gallery/4x3/300.webp https://mt.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374216564270080.html Studji Avvanzati Prekliniċi Inalazzjoni: Kapaċitajiet Tekniċi U Kompetenza Fuq Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://mt.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374263558366208.html Nifhmu l-Farmakokinetika (PK): Parametri ewlenin u Applikazzjonijiet fl-Iżvilupp tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://mt.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374263509525504.html Injezzjoni intracerebroventrikulari (ICV): Kunsinna ta' Preċiżjoni tas-CNS Għal Riċerka Preklinika https://mt.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://mt.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374216517985280.html Injezzjoni intraċerebrali (ICM): Immirar ta' Preċiżjoni Għat-Terapewtika tas-CNS - Konsiderazzjonijiet Prekliniċi https://img01.v15cdn.com/gallery/4x3/148.webp https://mt.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374263539688448.html Injezzjoni intratekali (IT): Rotta ta' Kunsinna Diretta tas-CNS Għal Terapiji Avvanzati - Konsiderazzjonijiet Prekliniċi https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374216436491264.html Avvanz tar-Riċerka dwar il-Mard ta' Parkinson Bil-Mudell NHP https://img01.v15cdn.com/gallery/4x3/300.webp https://mt.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374216782570496.html Studji Prekliniċi PK/PD & Mudelli NHP Għall-Iżvilupp tad-Droga|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://mt.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298957669639168.html Timmira ta' Interleukin-31 (IL-31): Fruntiera ġdida fl-Iżvilupp ta' Drogi tal-Mard Awtoimmuni - Mudelli Prisys Biotech NHP għal Riċerka Preklinika https://mt.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://mt.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295435110622208.html Valutazzjoni ta' Immunotossiċità Mhux Klinika: Strateġija, Konsiderazzjonijiet Ewlenin, U Għażla tal-Metodu https://img01.v15cdn.com/gallery/4x3/232.webp https://mt.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295434842072064.html L-Ittestjar Mikrobiku U l-Impatt tiegħu fuq Primati mhux-Bniedem fi Studji Prekliniċi DMPK https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295434933363712.html Mudell ta 'endometrijożi Cynomolgus Monkey għall-avvanz ta' riċerka terapewtika https://mt.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://mt.prisysbiotech.com/news/membranous-nephropathy-model-17295434774569984.html Avvanz Nefropatija Membranuża (MN) Żvilupp tad-Droga: Pjattaforma Mudell ta' Xadina Cynomolgus ta' Prisys Biotech https://img01.v15cdn.com/gallery/4x3/148.webp https://mt.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295459799081984.html Farmakokinetika ta' Drogi li jittieħdu man-nifs: Bidla ta' Paradigma minn Espożizzjoni Sistemika għal Pulmonari https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/animal-models-for-womens-health-17295434685752320.html Prisys Biotech: Mudelli ta 'Annimali Għat-Terapewtika tas-Saħħa tan-Nisa https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295435242939392.html Jum l-Obeżità Dinjija|Mudelli Metaboliċi Prisys Biotech NHP: Powering the Development of Next Generation Anti-Obesity Therapies https://mt.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://mt.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295434996638720.html Mudell ta 'Cynomolgus Monkey Psoriasis ta' Prisys Biotech: Avvanz ta 'Evalwazzjoni ta' Farmakodinamiċità Prekliniċi https://mt.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://mt.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295434804241408.html Integrazzjoni ta 'farmakokinetika u farmakodinamiċità fl-iżvilupp tad-droga https://mt.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://mt.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888303464997888.html On-Webinar fuq Talba|Il-Pont ta' Preċiżjoni: MRI-CED Iggwidata U Mudelli NHP Tradubbli Għall-Konsenja tad-Droga CNS https://mt.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://mt.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295435162739712.html X'Tivvalida l-Prova tal-Kunċett (PoC) fl-Iżvilupp tad-Droga? https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295434880148480.html Mudelli tal-Annimali|Sfidi U Applikazzjonijiet fl-Iżvilupp tal-Mudell ta' Uġigħ https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295435086062592.html Riċerka Farmakodinamika mhux klinika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243517646513152.html Għażla tal-Primat Ideali Mhux-Bniedem Għal Studji Tossikoloġija: Cynomolgus Macaque, Rhesus Macaque, U Marmoset https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81334111.html Terapija mmirata għall-Marda ta' Parkinson: Rivoluzzjoni f'-MRI f'ħin reali-Trapjant Iggwidat taċ-Ċelloli Staminali https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295434736362496.html Lupus Erythematosus Sistemiku (SLE) U L-Irwol tal-Mudelli tal-Annimali fl-Iżvilupp Terapewtiku https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295434751747072.html Mudell primat mhux uman għall-artrite rewmatojde (RA) https://mt.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://mt.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295434765444096.html Strumenti Stereotattiċi tal-Moħħ tal-Annimali Ibbażati Fuq Sistemi ta' Koordinati 3D https://mt.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://mt.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295435207975936.html Mudelli ta 'Annimali Għall-Ittestjar In Vivo (1): Stabbiliment U Klassifikazzjoni https://img01.v15cdn.com/gallery/4x3/148.webp https://mt.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83992071.html Nesploraw Rotot Potenzjali Għal Bijoloġiċi Biex Jidħlu Fil-Moħħ https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83992072.html Avvanz tar-Riċerka dwar l-Artrite Rewmatojde (RA) B'Mudelli ta' Primati Mhux Umani https://mt.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://mt.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83993186.html Nesploraw Mudelli ta 'Annimali Għall-Effikaċja tad-Droga Dermatite Atopika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83992077.html Ir-Rwol Kritiku tal-Mudelli tal-Annimali fir-Riċerka tal-Mard tal-Bniedem https://mt.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://mt.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83992104.html Il-Mudell tax-xadina tad-Defiċjenza tal-Ġene tal-Parkin Jiżvela Mekkaniżmi Ġodda U Miri Terapewtiċi Għall-Marda ta' Parkinson https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83992139.html Gwida għall-Iżvilupp tad-Droga mhux Klinika: Studji ta' Tossiċità Ġenerali Akuta, Subakuta, Subkronika, U Kronika https://mt.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://mt.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83992073.html Kunsinna Innovattiva tad-Droga mill-Imnieħer għall-Moħħ (N2B): Jevita l-Ostakolu Demm-Moħħ https://mt.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://mt.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83992074.html Opportunitajiet U Sfidi Ta 'Ħnieżer Mini Bħala Speċi ta' Annimali Kbir Mhux Klinika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83025293.html Strateġiji ta' Kunsinna tad-Droga Għall-Mard tal-Moħħ https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83028994.html Navigazzjoni MRI intraoperattiva fil--ħin reali: Appoġġ għall-Approvazzjoni tal-FDA tal-Ewwel Terapija tal-Ġene għal Defiċjenza tal-AADC https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83029267.html Studji ta 'Tossiċità Okulari Ta' Qtar għall-Għajnejn: Evalwazzjoni ta' Espożizzjoni U Sigurtà għad-Droga https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82760411.html Prisys Biotech Jistabbilixxi Mudell ta' Psorajiżi tax-xadina Cynomolgus Biex Tħaffef l-Iżvilupp tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82760417.html Mudelli Komprensivi ta' Primati Mhux-Bniedem għar-Riċerka tal-Mard Renali Minn Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82760409.html Evalwazzjoni Komprensiva ta' Sigurtà Preklinika Ta' Antikorpi-Konjugati tad-Droga (ADCs) fi Primati Mhux-Bniedem https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82760410.html Evalwazzjoni Farmakokinetika ta' Antikorpi-Konjugati tad-Droga (ADCs) fi Primati Mhux-Bniedem https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82760406.html Evalwazzjoni Farmakodinamika Ta 'ADCs https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82760711.html Nifhmu L-DMPK Ta 'Drogi ADC https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82760713.html Progress fl-iżvilupp ta 'drogi ta' aċidu nuklejku u l-kapaċitajiet ta 'riċerka ta' Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82311243.html Avvanzi fis-Sistemi ta' Kunsinna Pulmonari tal-mRNA U s-Servizzi Innovattivi ta' Prisys biotech https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82760712.html Għaliex Ingħata l-Premju Nobel 2024 fil-Fiżjoloġija jew il-Mediċina Lil Dawn iż-Żewġ Xjentisti li Studjaw il-MicroRNA? https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82760407.html Konsiderazzjonijiet Farmakokinetiċi (PK) Għal Mediċini tas-Sistema Nervuża Ċentrali (CNS). https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656502.html Avvanzi fir-Riċerka tas-CNS: MRI-Sistema Kompatibbli ta' Injezzjoni tal-Moħħ u Teknoloġija CED ta' Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://mt.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81334112.html Avvanz fl-Innovazzjonijiet Terapewtiċi ta' Fsada U Tagħqid Bil-Mudell MCAO ta' Cynomolgus Monkey https://mt.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://mt.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81334307.html Evalwazzjoni DMPK Ta 'Drogi tas-Sistema Nervuża Ċentrali (CNS). https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/animal-models-of-human-diseases-81334106.html Mudelli ta 'Annimali Ta' Mard tal-Bniedem https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81334105.html Innovazzjonijiet fl-Evalwazzjoni tal-Uġigħ: Analiżi tal-Imġieba Mmexxija mill-AI- https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/china-experimental-monkey-industry-81334107.html Storja, Status Kurrenti, Sfidi, U Opportunitajiet Ta 'l-Industrija Sperimentali taċ-Xadini taċ-Ċina https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/human-disease-animal-models-81334103.html Mudelli tal-Annimali tal-Mard tal-Bniedem: Għodda kruċjali għall-Avanz tar-Riċerka Bijomedika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81334102.html L-Importanza tal-Farmakodinamika Preklinika fl-Iżvilupp tad-Droga|Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://mt.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81334100.html Amministrazzjoni intranasali fl-Istudji fuq l-Annimali https://mt.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://mt.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79561515.html Revolutionizing CNS Drug Development: PRISYS Biotech Tintroduċi Teknoloġija IMRI https://mt.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://mt.prisysbiotech.com/news/convection-enhanced-delivery-81334104.html Avvanz fil-Mediċina ta' Preċiżjoni: Teknoloġija tal-Konvezzjoni-Enhanced Delivery (CED) Minn Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://mt.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81334101.html Cynomolgus Monkey Mard Kronika tal-Kliewi (CKD) Mudell Ta Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://mt.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79573874.html Evalwazzjoni tas-Sigurtà Mhux Klinika Ta 'Kunsinna Okulari tad-Droga Bl-Użu ta' Cynomolgus Macaques https://mt.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://mt.prisysbiotech.com/news/compartment-pk-model-81334309.html Nifhmu Mudelli Kompartimentali U Mhux-Farmakokinetiċi https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81334113.html Tekniki Avvanzati ta' Kunsinna tas-CNS fix-Xadini Cynomolgus: L-Aċċelerazzjoni tal-Iżvilupp tad-Droga Oligonucleotide https://mt.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://mt.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79573890.html It-Tnaqqis tal-Użu ta' Primati Mhux Umani f'Valutazzjonijiet tas-Sigurtà Mhux Kliniċi: Perspettivi Mill-FDA U l-Industrija https://mt.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://mt.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79573913.html Bijoanaliżi Preklinika LCMS Ta' Drogi ta' Terapija tal-Ġene bbażati fuq LNP- https://mt.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://mt.prisysbiotech.com/news/mrna-based-therapies-past-79573910.html Terapiji bbażati fuq MRNA-: Passat https://mt.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://mt.prisysbiotech.com/news/pk-strategies-of-pdc-79573871.html Strateġiji ta' Studju Farmakokinetiku ta' Peptide-Droga Conjugates (PDCs) https://mt.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://mt.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79573877.html Ir-Rwol Ta 'l-AAV fit-terapija tal-ġeni: Rispons Immune u Tossiċità https://mt.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://mt.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79573891.html Strateġiji Ottimizzati ta' Evalwazzjoni ta' Immunoġeniċità Mhux Klinika https://mt.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://mt.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79573909.html Evalwazzjoni Farmakodinamika (PD) tat-terapija tal-ġeni https://mt.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://mt.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79573906.html Farmakokinetika U Bijoanaliżi Ta' Drogi Oligonukleotidi-(1) https://mt.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://mt.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79573916.html Farmakokinetika U Bijoanaliżi Ta' Drogi Oligonukleotidi: Karatteristiċi Farmakokinetiċi (PK) ta' Assorbiment U Plażma https://mt.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://mt.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79573904.html Fatturi Biex Ikkunsidra Għall-Immunoġeniċità Ta 'Drogi Oligonukleotidi https://mt.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://mt.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79573914.html MRNA: Għodda Qawwija U Versatili Għall-Ġlieda Kontra l-Mard-Prisys-Bijoteknoloġija https://mt.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://mt.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79573894.html Xjentisti Ċiniżi joffru strateġiji ġodda biex ireġġgħu lura s-sintomi ewlenin tal-marda ta' Parkinson https://mt.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://mt.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79573899.html Bijoteknoloġija Prisys: Nanopartiċelli tal-Lipidi ġodda għall-Konsenja tal-MRNA fil-Primati https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79573896.html L-Importanza tar-Riċerka dwar il-Mediċina Translazzjonali Mir-Riċerka Bażika għal Studji Kliniċi https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79573903.html Il-Fatturi Ewlenin Ikkunsidra fl-Analiżi WOE https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79573901.html Kif Twassal Bijoloġiċi lill-Moħħ? https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79573897.html Kif Id-Drogi Jiċċaqilqu U Jinbidlu fil-Ġisem tagħna: Introduzzjoni Qasira Għall-Farmakokinetika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79573898.html Kif Tiżviluppa Drogi Ġodda Aktar Mgħaġġla U Sikura: Gwida Għal Studji Prekliniċi DMPK https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79573895.html Linji Gwida tad-Djar tal-Grupp Għax-xadini tal-Laboratorju https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79573900.html Ir-Rwol Vitali tax-xadini Sperimentali fl-Avvanz tar-Riċerka Xjentifika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79573902.html Nifhmu Macaca Fascicularis (Cynomolgus Monkey): Karatteristiċi Ewlenin U Kontribuzzjonijiet għar-Riċerka Bijomedika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79573892.html Revolutionizing Trattament tal-Mard Metaboliku: Avvanzi U Sfidi fl-Iżvilupp tad-Droga Peptidi https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79573886.html Kif Evalwa s-Sigurtà tal-Prodotti tal-Ġilda Qabel Provi Kliniċi? https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79573905.html Ir-Rwol Sinjifikanti tax-xadini Sperimentali fl-Iżvilupp Innovattiv tad-Droga: Ħarsa Ġewwa In-Negozju https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79573889.html Tossiċità tal-fwied Bħala Tħassib Ewlieni Għal Drogi SiRNA: Analiżi Komprensiva Speċifiċità fil-Mira: Is-Xabla Doppju-Tas-SiRNA https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79573884.html Avvanz SiRNA Therapeutics: Negħlbu l-Isfidi fl-Iżvilupp tad-Droga https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79573882.html Prospetti ta 'Applikazzjoni Ta' Drogi Ġene Ibbażati Fuq Nanopartiċelli Lipidi https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79573888.html Punti Ewlenin fit-Tfassil ta' Strateġiji Għal Studji Mhux-kliniċi Fuq Annimali Żgħar https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79573887.html Ħarsa lejn il-Karatteristiċi Sensorji u Komportamentali Ta' Primati Mhux-Bniedem (NHPs) https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79573893.html Valutazzjoni ta' Studju Mhux Klinika Q&A https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/significance-principles-and-requirements-of-79573917.html Sinifikat, Prinċipji, U Rekwiżiti tar-Riċerka Farmakoloġija tas-Sigurtà https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79573885.html Kif Evalwa l-Effikaċja Farmakoloġika Preklinika? https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79573878.html Riflessjonijiet Fuq Studji Farmakoloġija Mhux-kliniċi U Evalwazzjoni ta' Mediċini Terapewtiċi Għall-Steatoepatite Mhux-alkoħolika (NASH) https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79573875.html Avvanz tar-Riċerka CNS U CGT: Bijoteknoloġiji Prisys https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79573880.html Linji Gwida dwar il-Ġbir ta' Fluwidu Ċerebrospinali mhux-Uman Primate https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79573881.html Konsiderazzjonijiet Għall-Interpretazzjoni tad-Dejta tal-Patoloġija Klinika fi Primati Mhux-Uman (NHPs) U Kanini https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79573873.html ​​​​​​​Integrazzjoni tal-Evalwazzjoni tas-Sigurtà tas-CNS fi Studji Ġenerali tat-Tossikoloġija https://mt.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://mt.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79573883.html Kif Twettaq Evalwazzjoni Preklinika Farmakoloġija/Tossikoloġija Ta 'ADCs? https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79573879.html ADME Insights Għal Drogi Oligonukleotidi (1) - Assorbiment, Distribuzzjoni https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79573876.html Tagħrif ADME Għal Drogi Oligonukleotidi (2) - Metaboliżmu U Eskrezzjoni https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79573869.html Studji ta' qabel l-Annimali (1) - Speċi ta' Annimali https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79573872.html Sfidi u Strateġiji ta' Interpretazzjoni tad-Dejta tal-Patoloġija Klinika fi Studji Prekliniċi Ta' Kanini U Primati Mhux-umani https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79573915.html Studji Prekliniċi fuq l-Annimali (2) - Rotot U Volumi Ta' Amministrazzjoni https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/mrna-based-therapies-present-79573911.html Terapiji bbażati fuq MRNA-: Preżenti https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79573912.html Terapiji bbażati fuq MRNA-: Futur U Sfidi https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79573907.html Introduzzjoni Qasira Dwar Analiżi Bijoloġika tat-terapija tal-ġeni https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79561514.html Cynomolgus Monkey fir-Riċerka dwar id-Droga Oftalmika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79561516.html Studji Translazzjonali u Cross-Reattivi Mal-Mudelli NHP ta' Immunoloġija u Infjammazzjoni ta' Prisys https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79208810.html NHPs mhux-Naïve fi Provi Prekliniċi: Soluzzjoni Cost-Effective minn Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/nhp-asthma-model-79208802.html Mudell ta 'l-Ażma ta' NHP: Li Jagħti s-setgħa lill-Istudji Prekliniċi dwar l-Effikaċja tad-Droga Ma 'Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79208806.html Avvanz tar-Riċerka dwar l-Immunoloġija u l-Infjammazzjoni B'Mudelli ta' Cynomolgus Macaques - Prisys Biotechnologies https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79208803.html Kunsinna Diretta Ta' Drogi Oligonukleotidi Lis-CNS U Bidliet Istopatoloġiċi Komuni https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79208827.html Mudell Intra-Cerebrovascular Stroke (ICH) Ta' Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75179978.html Riċerka Farmakodinamika mhux{{0}klinika: Aspett Essenzjali fl-Iżvilupp ta' Drogi SiRNA https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77818721.html MRI-Sistema ta' Preċiżjoni tas-Sistema Nervuża Ċentrali Ggwidata ta' Annimali Kbir Is-Sistema ta' Lokalizzazzjoni u Kunsinna Tissetilja fi Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://mt.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77126539.html Soluzzjonijiet Innovattivi Għall-Avanz tat-Terapewtika Respiratorja https://mt.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://mt.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74822401.html Prisys: Avvanz ta' Esperimentazzjoni ta' Annimali Permezz ta' Studji ta' Cynomolgus Macaque https://mt.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://mt.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76263127.html Prisys Tikseb Akkreditazzjoni Sħiħa Minn AAALAC International: A Milestone fl-iżgurar ta 'Standards Għoli ta' Kura tal-Annimali tal-Laboratorju. https://mt.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://mt.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74710611.html Jgħolli t-Terapewtiċi tal-Aċidu Nuklejku Permezz tal-Qtugħ-B'Mudelli ta' Primati Mhux Umani Prisys Biotech https://mt.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://mt.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74277662.html Revolutionizing CNS Kunsinna tad-Droga: Prisys U Il-Wegħda Ta 'Injezzjoni Intrathecal https://img01.v15cdn.com/gallery/4x3/148.webp https://mt.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75179981.html Prisys Biotech 2024 Q1 Newsletter - l-ispeċjalista affidabbli tiegħek fl-istudju NonHuman Primate https://mt.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://mt.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73859525.html Kif Ultrasound-Bijopsija tal-Fwied Iggwidata Ttejjeb il-Makaw-Riċerka Ibbażata https://mt.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://mt.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73860572.html Linji Gwida Għall-Użu tul il-Ħajja ta' Primati Mhux Umani fir-Riċerka Bijomedika: Perspettiva tal-Bijoteknoloġija Prisys https://mt.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://mt.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73034605.html Primati mhux-umani: Introduzzjoni Qasira Għall-Karatteristiċi Bijoloġiċi Tagħhom https://mt.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://mt.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72716978.html Reviżjoni tal-Wirja|Prisys Biotech Tiddi Fil-Laqgħa Annwali tas-Soċjetà Amerikana għan-Newroxjenza (SfN 2023) https://mt.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://mt.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72337884.html Iltaqa' ma' Prisys Biotech Fil-Laqgħa Annwali tas-Soċjetà għan-Newroxjenza (SfN 2023) https://mt.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://mt.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72337887.html Il-Jum Dinji tal-Puplesija|Iffoka Fuq Mudelli U Farmakoloġija ta 'Annimali ta' Puplesija Iskemika https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72337885.html Prisys Biotech Tistiednek Tattendi Laqgħa Annwali SAPA-Ċina fl-2023 https://mt.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://mt.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72337883.html Il-Jum Dinji tal-Alzheimer|L-Isfidi U s-Soluzzjonijiet Għall-Iżvilupp tad-Droga AD https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72337882.html Il-Mudell tal-Annimali Cynomolgus Macaque ta' Prisys Biotech Jgħin L-Iżvilupp ta' Drogi Antikoagulanti Ġodda https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71026986.html Prisys: Provvediment ta' -Servizz ta' Esperiment tal-Annimali ta' Kwalità Għolja Għall-Antikorp Ġdid Anti-Fattur tal-Koagulazzjoni XI BJTJ-1837 https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71026987.html Metodu Għat-Twaqqif ta' Mudell ta' Xadina Cynomolgus Ta' Ipertrigliċeridemija U l-Applikazzjoni tiegħu https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71027236.html Farmakoloġija: Parametri Ewlenin U Sinifikat tal-Farmakokinetika (PK) https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71026985.html Evalwazzjoni Farmakoloġija Preklinika Ta 'Drogi tal-Virus Onkolitiċi https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/0-71027474.html Kif Drogi Żgħar ta' Aċidu Nuklejku Jistgħu Jitrasformaw It-Trattament tal-Mard tas-CNS: Intuwizzjonijiet Minn Prisys Biotechnology, Fornitur Ta' Mudelli ta' Mard NHP https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71028180.html Farmakokinetika, Strateġiji ta 'Riċerka U Studji ta' Każijiet ta 'Drogi Peptidi https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69667793.html Punti Ewlenin ta 'Riċerka Ta' ADC Drug PK https://img01.v15cdn.com/gallery/4x3/148.webp https://mt.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69667791.html Bijoteknoloġija Prisys: Mexxej fil-Pjattaforma ta' Riċerka dwar l-Immudellar tal-Mard tal-NHP CNS https://mt.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://mt.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309291.html Kif Titlef il-Piż U tikkontrolla d-Dijabete Bi Prodotti GLP-1 https://mt.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://mt.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309327.html Kif iċ-Ċina Monkey Tgħin Biex Twettaq Effiċjenza tar-Riċerka Preklinika? https://mt.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://mt.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309420.html X'Inhi L-Effiċjenza tal-RNAi? https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309328.html Pjattaforma ta' Servizz Pubbliku ta' Esperiment ta' Annimali Kbar Prisys Biotech: Soluzzjoni ta' Effiċjenza ta'-Spejjeż U Għoli- Għal Esperimenti ta' Annimali Kbar https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69075031.html Kif Terapija tal-Ġene AAV Tista' Tissalva l-Viżjoni Tiegħek: L-Aħħar Żviluppi Minn Studji dwar Primati Mhux-Bniedem https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69076467.html Prisys Biotech turi Pjattaforma Mudell ta' Primati mhux-umani fil-Laqgħa Annwali tas-Soċjetà Ġappuniża tat-Tossikoloġija https://mt.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://mt.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69075267.html Il-Futur promettenti tat-terapija tal-ġeni AAV fi primati mhux-umani https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69076470.html X'inhuma n-nanopartiċelli tal-lipidi għat-terapija tal-ġeni? https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69074591.html Prisys Biotech Jistiednek biex tipparteċipa fil-50 Laqgħa Annwali tas-Soċjetà Ġappuniża tat-Tossikoloġija (JSOT) https://mt.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://mt.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69075270.html Test ta' Immunotossiċità, Evalwazzjoni tas-Sigurtà tad-Droga-PRISYS BIOTECH https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68306048.html Mudell ta' l-Annimali Ottimi ta' Puplesija Iskemika Stabbilit Permezz ta' Angjografija ta' Tnaqqis Diġitali-Trombi Awtologi Iggwidati fix-xadini Cynomolgus https://mt.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://mt.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68132352.html Għaliex Għandek Jieħdu ħsieb Dwar Primati Mhux-Bniedem fis-Sistema ta' Kunsinna tad-Droga ta' Aċidu Nuklejku Riċerka u Żvilupp https://mt.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://mt.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68132365.html Iltaqa' ma' Prisys Biotech Fis-70 JALAS 2023! https://mt.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://mt.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68132357.html It-terapija tal-ġeni Tiddi B'Approvazzjonijiet Ġodda Għal Mard Rari https://mt.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://mt.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68132344.html Revolutioning Drug Discovery: Kif il-primati mhux umani qed jottimizzaw l-iskrining tas-SiRNA għal riżultati aktar veloċi u effiċjenti https://mt.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://mt.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67585712.html L-Immassimizzazzjoni tal-Effiċjenza tal-Farmakoloġija tas-SiRNA B'Riċerka dwar Primati Mhux Umani https://mt.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://mt.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67578407.html Kif Primati Mhux Umani Jistgħu Jirrivoluzzjonaw ir-Riċerka tas-SiRNA: Gwida Komprensiva https://mt.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://mt.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67600449.html Niċċelebraw il-Jum Dinji għall-Annimali tal-Laboratorju: Għaliex Prisys hija impenjata li tippromwovi s-saħħa tal-primati mhux umani https://mt.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://mt.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67579556.html L-Immassimizzazzjoni tal-Effiċjenza tar-Riċerka CRISPR/Cas9 B'Mudelli ta' Primati Mhux Umani https://mt.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://mt.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67590986.html Il-Ħruġ tal-Potenzjal Terapewtiku: Għaliex l-Investiment f'Drogi ta' Aċidu Nuklejku Huwa Il-Futur tal-Mediċina https://mt.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://mt.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67580370.html Nisfruttaw Il-Potenzjal Tal-Primati Mhux Umani fit-Titjib tal-Iskoperta tal-Mira tad-Droga tat-Terapija tal-Ġene https://mt.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://mt.prisysbiotech.com/news/world-parkinsons-disease-day-67577675.html Għaqqad Għall-Parkinson's: Ngħaqqdu l-Idejn Biex Inqajmu Kuxjenza dwar il-Jum Dinji tal-Mard ta' Parkinson https://mt.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://mt.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67580369.html Kif Uża Primati Mhux-Bniedem Effettivament fl-Evalwazzjoni tas-Sigurtà tat-Terapija tal-Ġene https://mt.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://mt.prisysbiotech.com/news/gene-therapy-toxicology-66275777.html Riċerka tat-Tossikoloġija tat-Terapija tal-Ġene Bil-Primata Nonhuam https://mt.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://mt.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66148627.html Gwida Komprensiva Għat-Tmexxija ta' Studju DMPK Għat-Terapija tal-Ġene https://mt.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://mt.prisysbiotech.com/news/gene-therapy-nhp-model-66147915.html Rivoluzzjoni tar-Riċerka Medika: Żviluppi fit-terapija tal-ġeni f'mudelli ta' mard tal-primati mhux umani! https://mt.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://mt.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66147916.html L-Aqwa 10 Mistoqsijiet Popolari Relatati Mat-Terapija tal-Ġene https://mt.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://mt.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66147912.html Prisys Biotech: Farmakoloġija ta' Primati Mhux-Bniedem Għat-Terapija tal-Ġene https://mt.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://mt.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66148628.html Appoġġ għas-Saħħa tan-Nisa: Ħarsa lejn Endometriosis https://mt.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://mt.prisysbiotech.com/news/prisys-sot2023-66147914.html PRISYS And Taichu Group Are Collaborating For The SOT Exhibition in 2023 https://mt.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://mt.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66147913.html Neħtieġu Aktar Studji Għall-Valutazzjoni tal-Uġigħ? - NHP https://mt.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://mt.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66147909.html Ingħaqad magħna biex niċċelebraw il-Jum Dinji tal-Ħajja Selvaġġa https://mt.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://mt.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66147910.html Tnedija taċ-Ċentru tar-R&D NHP Prisys Shanghai, li jimmarka Tragward fir-Riċerka u l-Iżvilupp Farmaċewtiċi fiċ-Ċina https://mt.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://mt.prisysbiotech.com/news/meetprisys-sot2023-66147908.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://mt.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg